PTH and myelofibrosis: Thirdly, increased PTH levels can lead to myelofibrosis and cardiac fibrosis in ESRD and may mediate cardiovascular fibrosis and apoptosis through the TGF-β signaling pathway, resulting in a hyperinflammatory state (66–68).